Physician profile
Rebecca Emory
NPI 1245798057
$39,770.00
in general payments reported to CMS, 2019-2025
45 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.89 · 2022: $196 · 2023: $7,311 · 2024: $13K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,620 · Travel and Lodging: $5,832 · Consulting Fee: $3,680 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,917.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,620.00 |
| Travel and Lodging | $5,832.17 |
| Consulting Fee | $3,680.00 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $8,236.93 | 2024-2025 | Daybue |
| Ucb, INC. | $8,226.38 | 2022-2025 | Fintepla, Briviact, Nayzilam |
| Livanova USA, INC. | $7,005.91 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Catalyst Pharmaceuticals, INC. | $3,700.09 | 2023-2025 | Fycompa |
| Abbvie INC. | $1,773.85 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $1,472.31 | 2023-2025 | |
| Neurelis, INC. | $1,405.88 | 2022-2025 | Valtoco |
| Pfizer INC. | $1,147.88 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $899.84 | 2023-2025 | Qelbree, Qelbree, Oxtellar Xr |
| Sk Life Science, INC. | $562.01 | 2023-2025 | |
| Impel Pharmaceuticals INC. | $559.77 | 2023 | Trudhesa |
| Azurity Pharmaceuticals, INC. | $543.23 | 2024-2025 | Zonisade |
| Teva Pharmaceuticals USA, INC. | $371.87 | 2023-2025 | Ajovy, Austedo Xr, Austedo |
| Lilly USA, LLC | $340.55 | 2023-2024 | Emgality, Reyvow |
| Sumitomo Pharma America, INC. | $327.91 | 2023-2024 | Aptiom |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $324.23 | 2023-2024 | Jornay Pm |
| Immedica Pharma US, INC. | $312.34 | 2023-2025 | Ztalmy |
| Axsome Therapeutics, INC. | $287.74 | 2023-2025 | Auvelity, Symbravo |
| Biocodex, INC. | $236.57 | 2023-2025 | Diacomit |
| Merz Pharmaceuticals, LLC | $218.29 | 2023-2025 | Xeomin, Inbrija |
| Lundbeck LLC | $213.72 | 2025 | Vyepti |
| Neos Therapeutics, Lp | $184.47 | 2023 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Amgen INC. | $151.34 | 2023 | Aimovig |
| Tonix Medicines, INC. | $149.78 | 2024 | Zembrace Symtouch |
| Alexion Pharmaceuticals, INC. | $136.52 | 2025 | Strensiq |
| Collegium Pharmaceutical, INC. | $117.89 | 2025 | Jornay Pm |
| Tris Pharma INC | $117.55 | 2023-2025 | Dyanavel Xr, Onyda Xr |
| Ipsen Biopharmaceuticals, INC | $94.80 | 2023-2025 | Dysport |
| Otter Pharmaceuticals, LLC | $90.69 | 2025 | Sympazan |
| Inspire Medical Systems, INC. | $80.74 | 2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $60.76 | 2023 | Gammagard |
| Eisai INC. | $59.64 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $52.72 | 2023-2024 | Rexulti |
| Aucta Pharmaceuticals, INC. | $48.74 | 2024-2025 | Motpoly Xr |
| Corium, LLC | $38.31 | 2025 | Azstarys |
| Cranial Technologies, INC | $38.13 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $26.73 | 2025 | Spravato |
| Aquestive Therapeutics, INC. | $24.84 | 2025 | |
| Noven Therapeutics, LLC | $23.74 | 2023 | Xelstrym |
| Scilex Pharmaceuticals INC. | $21.78 | 2023 | Ztlido |
| Biogen, INC. | $19.57 | 2025 | Skyclarys |
| Upsher-Smith Laboratories LLC | $18.14 | 2023 | |
| Sanofi Pasteur INC. | $17.20 | 2022 | |
| Amneal Pharmaceuticals LLC | $15.87 | 2023 | Lyvispah |
| Kaleo, INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Emory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.